News and Trends 4 Sep 2024 2024: a year of breakthroughs for endometrial cancer? …Rochester OKN-007 – Oblato, Inc ADCs: new treatments see encouraging results in clinic Another advancement in endometrial cancer research is the development of antibody drug conjugates (ADCs) that are “designed… September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 14 Apr 2023 TORL BioTherapeutics launches with $158M to target cancer …pipeline of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) were discovered in the laboratory of scientific co-founder Dennis Slamon, professor of medicine, and chief of the division of hematology/oncology at… April 14, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2022 GSK to acquire clinical-stage biopharmaceutical company Affinivax …broader coverage against prevalent pneumococcal variants and potentially creates higher immune responses than current vaccines. Affinivax’s most advanced vaccine candidate (AFX3772) includes 24 pneumococcal polysaccharides plus two conserved pneumococcal proteins… June 1, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 2 Nov 2023 How French pharma giant Sanofi is betting big on AI …two companies agreed to a research and licensing agreement to develop up to 15 small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples…. November 2, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 19 Feb 2018 The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease The FDA has awarded Hansa Medical’s lead candidate for the treatment of an autoimmune disease with Orphan Drug Designation, which will support its journey through clinical development. Swedish biotech, Hansa… February 19, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 19 Nov 2020 mRNA Stocks Soar with Final Results of BioNTech’s Covid-19 Vaccine …over 43,000 volunteers to gauge whether Covid-19 infections could be prevented by a vaccine made out of messenger RNA (mRNA). One group received two doses of the candidate vaccine around… November 19, 2020 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 3 Apr 2017 First Treatment for Severe Premenstrual Syndrome Clears Phase II Swedish Asarina Pharma has announced positive results of a Phase IIa study for the treatment of Premenstrual Dysphoric Disorder (PMDD). With only a single product candidate in its pipeline, Asarina… April 3, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 18 Nov 2022 MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma …the investment to explore the potential of DSP107, KAHR’s leading immunotherapy drug candidate for the treatment of multiple myeloma. “We are thrilled to partner with KAHR to help advance DSP107… November 18, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 4 Apr 2024 Seven diseases CRISPR technology could cure …companies in this space, developing off-the-shelf, gene-edited T cell therapies using CRISPR, with two candidates – targeting CD19 and CD70 proteins – in clinical trials. In 2022, the FDA granted… April 4, 2024 - 11 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 29 Jun 2020 Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials …candidate therapy — comprising three OncoMimic proteins — into two phase I/II trials. One trial will test the candidate treatment in patients with the aggressive brain cancer glioblastoma and the… June 29, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2016 Boehringer buys a €210M ticket to Virus-based Immuno-Oncology …compete with other well-known immuno-oncology therapies like CAR-T or TCR. Both companies will collaborate to develop a next-generation platform of oncolytic viruses and advance ViraTherapeutics’ lead candidate, VSV-GP. This candidate… September 29, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Expert Advice 17 May 2024 How to use LinkedIn to ace your biotech job search and advance your career …have the time to do all the candidate research themselves but when they ask for recruiters’ help, they often don’t have the time to train the candidates. There’s no harm… May 17, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email